Drug Profile
Propargylglycine
Alternative Names: PPGLatest Information Update: 21 Oct 2021
Price :
$50
*
At a glance
- Originator Unknown
- Developer Nonindustrial source
- Class Alkynes; Amino acids; Antineoplastics
- Mechanism of Action Enzyme inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 14 Dec 2001 No-Development-Reported for Cancer in Japan (Unknown route)
- 22 Dec 1994 Preclinical development for Cancer in Japan (Unknown route)